tiprankstipranks
Trending News
More News >
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
ASX:ONE

Oneview Healthcare Chess Depository Interests repr 1 (ONE) AI Stock Analysis

Compare
8 Followers

Top Page

AU

Oneview Healthcare Chess Depository Interests repr 1

(Sydney:ONE)

Rating:41Neutral
Price Target:
AU$0.50
▲(92.31%Upside)
The overall stock score for Oneview Healthcare is primarily driven by poor financial performance and weak technical indicators. The lack of profitability, negative cash flows, and bearish technical signals significantly impact its investment appeal.

Oneview Healthcare Chess Depository Interests repr 1 (ONE) vs. iShares MSCI Australia ETF (EWA)

Oneview Healthcare Chess Depository Interests repr 1 Business Overview & Revenue Model

Company DescriptionOneview Healthcare PLC develops and sells software and related consultancy services for the healthcare sector in Ireland, the United States, Australia, Asia, and the Middle East. The company operates Care Experience Platform (CXP) Cloud Start that allows customers to implement critical digital engagement capabilities across their entire enterprise; CXP Cloud Enterprise, which gives patients and their families the ability to communicate virtually with healthcare teams along with access to education and health information; and CXP Enterprise On-Prem that meets enterprise needs across various types of facilities from new construction to existing hospitals with legacy wiring. It also provides empower patients and families, manage patient experience, deliver virtual care, digital door sign, and patient communication board solutions. The company was founded in 2008 and is based in Dublin, Ireland.
How the Company Makes MoneyOneview Healthcare generates revenue primarily through the sale and licensing of its patient engagement platform to hospitals and healthcare facilities. The company employs a subscription-based model for its software solutions, which provides a steady stream of recurring revenue. Additionally, Oneview benefits from implementation fees for initial system setup and ongoing support and maintenance services. Strategic partnerships with healthcare providers and technology companies also contribute to its earnings by expanding its market reach and enhancing its product offerings.

Oneview Healthcare Chess Depository Interests repr 1 Financial Statement Overview

Summary
Oneview Healthcare presents a mixed financial picture. While there is some growth in revenue and equity, persistent losses and negative cash flows are concerning. The company needs to focus on improving operational efficiency and profitability to enhance financial health and sustainability.
Income Statement
35
Negative
The company has struggled with profitability, evident from consistent negative EBIT and net income figures over recent years. Revenue has shown modest growth, with a 5.3% increase from 2023 to 2024, but margins remain under pressure. The Gross Profit Margin improved slightly, indicating some operational efficiency, yet the persistent net losses hinder overall performance.
Balance Sheet
40
Negative
The balance sheet shows a moderate debt-to-equity ratio, reflecting relatively low leverage. However, the company's equity ratio has been fluctuating, indicating instability in asset financing. Although stockholders' equity has grown, it remains susceptible to ongoing net losses. The overall equity position is improving but remains fragile.
Cash Flow
30
Negative
Cash flow from operations is consistently negative, which, combined with capital expenditures, results in negative free cash flow. There is a reliance on financing activities to support cash flow, which could pose risks if external funding becomes less available. The ratio of operating cash flow to net income indicates that cash generation efficiency is low.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
9.89M9.40M8.92M9.73M7.10M
Gross Profit
6.67M6.16M5.35M5.31M4.72M
EBIT
-11.36M-8.37M-10.76M-8.01M-8.23M
EBITDA
-11.26M-7.88M-15.38M-7.42M-8.18M
Net Income Common Stockholders
-10.84M-8.93M-10.87M-8.19M-9.45M
Balance SheetCash, Cash Equivalents and Short-Term Investments
13.83M11.55M6.41M15.18M6.80M
Total Assets
25.96M21.92M12.75M21.09M14.25M
Total Debt
1.15M935.32K543.01K1.20M1.51M
Net Debt
-12.68M-10.61M-5.87M-13.97M-5.29M
Total Liabilities
12.71M12.78M10.50M11.19M10.18M
Stockholders Equity
13.25M9.14M2.26M9.90M4.07M
Cash FlowFree Cash Flow
-10.52M-7.79M-10.24M-4.09M-7.94M
Operating Cash Flow
-10.47M-7.26M-10.20M-4.03M-7.69M
Investing Cash Flow
-459.78K-521.38K-44.52K-65.26K-249.35K
Financing Cash Flow
13.14M13.04M-100.11K12.22M4.95M

Oneview Healthcare Chess Depository Interests repr 1 Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.26
Price Trends
50DMA
0.27
Negative
100DMA
0.29
Negative
200DMA
0.31
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
40.91
Neutral
STOCH
45.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ONE, the sentiment is Negative. The current price of 0.26 is below the 20-day moving average (MA) of 0.27, below the 50-day MA of 0.27, and below the 200-day MA of 0.31, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.91 is Neutral, neither overbought nor oversold. The STOCH value of 45.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ONE.

Oneview Healthcare Chess Depository Interests repr 1 Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$5.31B3.26-45.10%2.79%16.76%0.02%
AUONE
41
Neutral
$200.85M
5.87%4.06%
$141.79M19.8417.87%
$54.99M-9.88%
AUBMT
57
Neutral
AU$85.60M-11.80%14.56%13.36%
AUPCK
55
Neutral
AU$73.68M-457.46%21.93%10.34%
AUALC
54
Neutral
AU$126.24M-5.63%-11.96%7.50%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.26
-0.07
-21.21%
COGZF
Cogstate Ltd
0.87
0.13
17.57%
TDMMF
Mach7 Technologies
0.24
-0.12
-33.33%
AU:BMT
Beamtree Holdings Ltd
0.30
0.08
36.36%
AU:ALC
Alcidion Group Limited
0.09
0.04
80.00%
AU:PCK
PainChek Ltd
0.04
0.01
33.33%

Oneview Healthcare Chess Depository Interests repr 1 Corporate Events

Oneview Healthcare PLC Announces Quotation of New Securities
May 16, 2025

Oneview Healthcare PLC announced the quotation of 1,232,788 CHESS Depositary Interests on the Australian Securities Exchange, marking a significant step in its strategic financial operations. This move is expected to enhance the company’s market presence and provide greater flexibility in its capital management, potentially benefiting stakeholders and reinforcing its position in the healthcare technology sector.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Reports Strong Q1 2025 with Strategic Expansions and Innovations
Apr 23, 2025

Oneview Healthcare PLC reported a net cash outflow of €1.6 million for Q1 2025, with strong customer receipts inflows of €4.2 million, reflecting improved financial performance compared to the previous year. The company is actively expanding its market presence through strategic partnerships and product innovations, including the launch of its AI-driven Virtual Patient Assistant, Ovie. The company is also progressing with significant deployment projects and is in contract negotiations with major healthcare systems, positioning itself for continued growth despite potential tariff impacts.

Oneview Healthcare Director Adjusts CDI Holdings Amid RSU Vesting
Mar 12, 2025

Oneview Healthcare PLC has announced a change in the director’s interest notice, specifically involving Barbara Nelson. The change includes the acquisition of 208,333 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs) and the sale of 102,083 CDIs to settle mandatory Irish payroll income taxes. This adjustment results in a net increase in Nelson’s holdings, reflecting a strategic move to manage tax obligations while maintaining a significant stake in the company.

Oneview Healthcare Director Increases Stake Through RSU Vesting
Mar 12, 2025

Oneview Healthcare PLC has announced a change in the director’s interest, with Darragh Lyons acquiring 150,000 Chess Depository Interests (CDIs) as a result of the vesting of Restricted Share Units (RSUs). This change reflects an increase in the director’s holdings, indicating confidence in the company’s future performance and potentially impacting stakeholder perceptions positively.

Oneview Healthcare Announces New Securities Quotation on ASX
Mar 10, 2025

Oneview Healthcare PLC has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company will be quoting 3,778,728 CHESS Depositary Interests, which were previously issued under an employee incentive scheme. This move is likely to impact the company’s market presence by increasing its visibility and potentially attracting more investors.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.